{"id":48757,"date":"2025-11-21T21:47:02","date_gmt":"2025-11-21T13:47:02","guid":{"rendered":"https:\/\/flcube.com\/?p=48757"},"modified":"2025-11-21T21:47:04","modified_gmt":"2025-11-21T13:47:04","slug":"fda-pilot-program-offers-meeting-minute-clarification-to-drug-sponsors","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=48757","title":{"rendered":"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors"},"content":{"rendered":"\n<p>The <strong>U.S. Food and Drug Administration (FDA)<\/strong> announced a pilot program designed to streamline post\u2011meeting communications with sponsors, introducing a <strong>\u201cMeeting Minute Clarification Opportunity\u201d<\/strong> that allows pharmaceutical companies to obtain single\u2011discipline clarifications via email within <strong>three business days<\/strong>, potentially sparing months of regulatory guesswork.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-innovation\">Regulatory Innovation<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Agency<\/strong><\/td><td>FDA Office of New Drugs (initial pilot)<\/td><\/tr><tr><td><strong>Program Name<\/strong><\/td><td>Meeting Minute Clarification Opportunity<\/td><\/tr><tr><td><strong>Launch Date<\/strong><\/td><td>19\u202fNov\u202f2025 (pilot phase)<\/td><\/tr><tr><td><strong>Response Time<\/strong><\/td><td>3 business days (target)<\/td><\/tr><tr><td><strong>Clarification Scope<\/strong><\/td><td>Single\u2011discipline questions following formal meeting minutes<\/td><\/tr><tr><td><strong>Submission Method<\/strong><\/td><td>Email to designated review team<\/td><\/tr><tr><td><strong>Expansion Plan<\/strong><\/td><td>Rollout across all FDA centers planned<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-program-mechanism\">Program Mechanism<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Process:<\/strong> Sponsors submit a concise email question; FDA review discipline responds directly within three business days<\/li>\n\n\n\n<li><strong>Eligibility:<\/strong> Open to all drug and biologic sponsors following formal meetings (Type\u202fA, B, C)<\/li>\n\n\n\n<li><strong>Benefit:<\/strong> Eliminates <strong>2\u20114 months<\/strong> of ambiguity that often delays development decisions and protocol amendments<\/li>\n\n\n\n<li><strong>Cost Impact:<\/strong> Industry estimates suggest each clarification saves sponsors <strong>$150,000\u2011$400,000<\/strong> **in internal review cycles and external consulting fees<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-outlook\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>Value<\/th><\/tr><\/thead><tbody><tr><td><strong>Sponsors Affected<\/strong><\/td><td>~1,200\u20111,500 formal FDA meetings annually<\/td><\/tr><tr><td><strong>Average Clarifications per Meeting<\/strong><\/td><td>1\u20112 issues requiring follow\u2011up<\/td><\/tr><tr><td><strong>Time Savings per Clarification<\/strong><\/td><td>6\u20118 weeks vs. traditional feedback loops<\/td><\/tr><tr><td><strong>Potential Cycle Time Reduction<\/strong><\/td><td>5\u201110% faster overall development timeline for responsive programs<\/td><\/tr><tr><td><strong>Competitive Positioning<\/strong><\/td><td>Enhances FDA responsiveness relative to <strong>EMA<\/strong> and <strong>PMDA<\/strong>, potentially attracting earlier\u2011stage filings<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Industry Reception:<\/strong> Trade group <strong>PhRMA<\/strong> praised the initiative as a \u201cpragmatic step toward modernizing regulatory interactions.\u201d<\/li>\n\n\n\n<li><strong>Adoption Risk:<\/strong> Success depends on discipline\u2011level resourcing; FDA plans to allocate <strong>2\u20113 FTEs<\/strong> per review division to manage the queue.<\/li>\n\n\n\n<li><strong>Next Phase:<\/strong> Pilot evaluation in <strong>Q2\u202f2026<\/strong>; if targets are met, full agency rollout by <strong>Q4\u202f2026<\/strong>.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the FDA pilot program\u2019s expansion timeline, sponsor adoption rates, and impact on drug development efficiency. Actual results may differ due to resource constraints, policy changes, and variability in sponsor utilization.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration (FDA) announced a pilot program designed to streamline post\u2011meeting&#8230;<\/p>\n","protected":false},"author":1,"featured_media":48758,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[],"class_list":["post-48757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The U.S. Food and Drug Administration (FDA) announced a pilot program designed to streamline post\u2011meeting communications with sponsors, introducing a \u201cMeeting Minute Clarification Opportunity\u201d that allows pharmaceutical companies to obtain single\u2011discipline clarifications via email within three business days, potentially sparing months of regulatory guesswork.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=48757\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors\" \/>\n<meta property=\"og:description\" content=\"The U.S. Food and Drug Administration (FDA) announced a pilot program designed to streamline post\u2011meeting communications with sponsors, introducing a \u201cMeeting Minute Clarification Opportunity\u201d that allows pharmaceutical companies to obtain single\u2011discipline clarifications via email within three business days, potentially sparing months of regulatory guesswork.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=48757\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-21T13:47:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-21T13:47:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2103.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors\",\"datePublished\":\"2025-11-21T13:47:02+00:00\",\"dateModified\":\"2025-11-21T13:47:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757\"},\"wordCount\":323,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2103.webp\",\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=48757#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=48757\",\"name\":\"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2103.webp\",\"datePublished\":\"2025-11-21T13:47:02+00:00\",\"dateModified\":\"2025-11-21T13:47:04+00:00\",\"description\":\"The U.S. Food and Drug Administration (FDA) announced a pilot program designed to streamline post\u2011meeting communications with sponsors, introducing a \u201cMeeting Minute Clarification Opportunity\u201d that allows pharmaceutical companies to obtain single\u2011discipline clarifications via email within three business days, potentially sparing months of regulatory guesswork.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=48757\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2103.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2103.webp\",\"width\":1080,\"height\":608,\"caption\":\"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48757#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors - Insight, China&#039;s Pharmaceutical Industry","description":"The U.S. Food and Drug Administration (FDA) announced a pilot program designed to streamline post\u2011meeting communications with sponsors, introducing a \u201cMeeting Minute Clarification Opportunity\u201d that allows pharmaceutical companies to obtain single\u2011discipline clarifications via email within three business days, potentially sparing months of regulatory guesswork.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=48757","og_locale":"en_US","og_type":"article","og_title":"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors","og_description":"The U.S. Food and Drug Administration (FDA) announced a pilot program designed to streamline post\u2011meeting communications with sponsors, introducing a \u201cMeeting Minute Clarification Opportunity\u201d that allows pharmaceutical companies to obtain single\u2011discipline clarifications via email within three business days, potentially sparing months of regulatory guesswork.","og_url":"https:\/\/flcube.com\/?p=48757","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-21T13:47:02+00:00","article_modified_time":"2025-11-21T13:47:04+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2103.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=48757#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=48757"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors","datePublished":"2025-11-21T13:47:02+00:00","dateModified":"2025-11-21T13:47:04+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=48757"},"wordCount":323,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=48757#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2103.webp","articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=48757#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=48757","url":"https:\/\/flcube.com\/?p=48757","name":"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=48757#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=48757#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2103.webp","datePublished":"2025-11-21T13:47:02+00:00","dateModified":"2025-11-21T13:47:04+00:00","description":"The U.S. Food and Drug Administration (FDA) announced a pilot program designed to streamline post\u2011meeting communications with sponsors, introducing a \u201cMeeting Minute Clarification Opportunity\u201d that allows pharmaceutical companies to obtain single\u2011discipline clarifications via email within three business days, potentially sparing months of regulatory guesswork.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=48757#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=48757"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=48757#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2103.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2103.webp","width":1080,"height":608,"caption":"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=48757#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2103.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48757"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48757\/revisions"}],"predecessor-version":[{"id":48759,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48757\/revisions\/48759"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/48758"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}